Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
There is a widespread acceptance in the literature that plasma nonesterified fatty acids (NEFA), also called free fatty acids (FFA), can mediate many adverse metabolic effects, most notably insulin resistance. Elevated NEFA concentrations in obesity are thought to arise from an increased adipose tissue mass. It is also argued that the process of fatty acid mobilization from adipose tissue, normally suppressed by insulin, itself becomes insulin resistant—thus, lipolysis is further increased, potentially leading to a vicious cycle. Although we have also accepted this model for many years (1,2), recently there has been a steady accumulation of data, both in the literature and from our own research, that has forced us to realize that this simple story is not always true. Here we review the background to the idea of “fatty acids as metabolic villains,” together with data from the literature and from our own studies, which tend to show another side to the fatty acids/insulin resistance story. We will first examine the relationship between systemic concentrations of NEFA and obesity/insulin resistance and then study adipose tissue in the obese state with regard to its adaptation for NEFA release. NEFA circulate in the plasma bound to plasma albumin. Their function was largely elucidated in the 1950s through the work of Vincent Dole (3) at the Rockefeller Institute in New York and Robert Gordon (4,5) at the National Institutes of Health. Gordon demonstrated the origin of plasma NEFA from adipose tissue and their use by tissues such as the liver and myocardium, but not the brain. We now recognize that NEFA are the vehicle by which triacylglycerol (TG) stored in adipose tissue is transported to its sites of utilization. NEFA turnover is rapid, with a plasma half-life around 2–4 min (6). The only significant site of NEFA liberation …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The amount of liberated FFA from chylomicrons and VLDL depends on the activity of LPL, which is stimulated by insulin [17,18].”
From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [17]
Experimental — accuracy not yet measuredIn the citing paper
“These observations suggest that carbohydrate restriction reduces insulin secretion, which may facilitate fat mobilization (33), particularly from the intra-abdominal area, a depot associated with metabolic dysfunction that is enlarged in individuals with T2D (34,35).”
From A Lower-Carbohydrate, Higher-Fat Diet Reduces Abdominal and Intermuscular Fat and Increases Insulin Sensitivity in Adults at Risk of Type 2 Diabetes (2015) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705 · cited 1×
“With this approach, it is easy to show that elevated NEFA concentrations are associated acutely with insulin resistance, both with peripheral glucose uptake (33,34) and hepatic gluconeogenesis (35,36) and with impaired glucose tolerance (37).”
BackgroundA RELATION BETWEEN NON-ESTERIFIED FATTY ACIDS IN PLASMA AND THE METABOLISM OF GLUCOSE
Dole, V. P. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103259 · Cited by 3,454 · cited 1×
“Their function was largely elucidated in the 1950s through the work of Vincent Dole (3) at the Rockefeller Institute in New York and Robert Gordon (4,5) at the National Institutes of Health.”
BackgroundRomijn, J. A., Coyle, E. F., Sidossis, L. S., Gastaldelli, A., Horowitz, J. F., Endert, E., & Wolfe, R. R. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.3.e380 · Cited by 1,747 · cited 1×
“somewhat (2), but often plasma NEFA concentrations remain relatively stable as removal by muscle increases to match adipose tissue lipolysis (27,28).”
BackgroundLipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100 · cited 1×
“The detrimental effects on insulin sensitivity and other cellular processes are known as lipotoxicity (57).”
BackgroundSplanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933 · cited 1×
“The abdominal subcutaneous fat depot is the dominant source of NEFA; considerably less comes from leg adipose tissue and—against popular belief—only a small proportion of the systemic NEFA concentrations arises from intraabdominal adipose tissue (7).”
BackgroundLipolysis and lipid mobilization in human adipose tissue
Lafontan, M., & Langin, D. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.05.001 · Cited by 826 · cited 1×
“It has been reviewed recently (8), and we will not cover those aspects here.”
BackgroundGroop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812 · cited 2×
“The rationale for this supposition comes from the fact that adipose tissue could be seen as insulin resistant in obesity and therefore as not responding adequately to the antilipolytic action of insulin (29).”
Background
Cited by
Items 301–400 of 894
Tzeng, T., Lu, H.-J., Liou, S., Chang, C. J., & Liu, I.-M. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.09.017 · Cited by 34
The Underlying Chemistry of Electronegative LDL’s Atherogenicity
Ke, L., Stancel, N., Bair, H., & Chen, C. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0428-y · Cited by 35
Kowalski, G. M., Hamley, S., Selathurai, A., Kloehn, J., Souza, D. P. D., O’Callaghan, S., Nijagal, B., Tull, D., McConville, M. J., & Bruce, C. R. (2016) · Scientific Reports · doi:10.1038/srep27541 · Cited by 39
The Role of Obesity in Breast Cancer Pathogenesis
Glassman, I., Le, N., Asif, A., Goulding, A., Alcantara, C. A., Vu, A., Chorbajian, A., Mirhosseini, M., Singh, M., & Venketaraman, V. (2023) · Cells · doi:10.3390/cells12162061 · Cited by 47
“Hussey et al. found that increased circulating levels of NEFAs resulted in increased expression of TLR3, TLR4, TLR5, several mitogen-activated kinases (MAPK), and inhibitor of kappa B (IκB) kinase (IKK)-nuclear factor kB (NFκB) [29].”
BackgroundInfluentialBody Weight Regulation and Obesity: Dietary Strategies to Improve the Metabolic Profile
Munsters, M. J. M., & Saris, W. H. M. (2014) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030212-182557 · Cited by 39
Proteomics of Skeletal Muscle: Focus on Insulin Resistance and Exercise Biology
Deshmukh, A. S. (2016) · Proteomes · doi:10.3390/proteomes4010006 · Cited by 38
“Type 2 diabetes patients are characterized by a decreases oxidative capacity and high circulating free fatty acids (FFA) [82].”
BackgroundPathogenesis and remission of type 2 diabetes: what has the twin cycle hypothesis taught us?
Al-Mrabeh, A. H. (2020) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000201 · Cited by 38
Chuang, W.-T., Yen, C., Huang, C., Chen, H., & Lii, C. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c06269 · Cited by 36
Miklánková, D., Marková, I., Hüttl, M., Staňková, B., & Malínská, H. (2022) · Journal of Diabetes Research · doi:10.1155/2022/4587907 · Cited by 40
“Although elevated NEFA are sometimes associated with insulin-resistant states, many studies over several decades have demonstrated that elevated plasma NEFA levels are not necessarily linked to impaired IS [18].”
BackgroundShen, L., Gan, M., Zhang, S., Ma, J., Tang, G., Jiang, Y., Li, M., Wang, J., Li, X., Che, L., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00291 · Cited by 36
Engin, B., Willis, S. A., Malaikah, S., Sargeant, J. A., Yates, T., Gray, L. J., Aithal, G. P., Stensel, D. J., & King, J. A. (2022) · Obesity Reviews · doi:10.1111/obr.13445 · Cited by 31
Vitale, M., Costabile, G., Bergia, R. E., Hjorth, T., Campbell, W. W., Landberg, R., Riccardi, G., & Giacco, R. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.08.016 · Cited by 33
Bonzón‐Kulichenko, E., Moltó, E., Pintado, C., Fernández, A., Arribas, C., Schwudke, D., Gallardo, N., Shevchenko, A., & Andrés, A. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly081 · Cited by 40
Tung, Y., Zeng, J., Ho, S., Xu, J.-W., Lin, I., & Wu, J. (2021) · Antioxidants · doi:10.3390/antiox11010045 · Cited by 33
“Insulin resistance is attributable to an imbalance between hepatic glucose production and tissue uptake [47,48].”
BackgroundPark, J.-E., Lim, H. R., Kim, J. W., & Shin, K. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.045 · Cited by 33
Free fatty acid as an outcome predictor of atrial fibrillation–associated stroke
Choi, J., Jung, J., Kwon, D., Park, M. H., Kim, J. H., Oh, K., Koh, S., & Seo, W. (2015) · Annals of Neurology · doi:10.1002/ana.24568 · Cited by 30
“After starvation such as overnight fasting, catecholamine release stimulates lipolysis of triglycerides in adipocytes.26 Because FFA is a key component of lipid metabolism, elevation of FFA concentration is mostly seen in obesity and metabolic syndrome with their characteristic lipid profile, hypertriglyceridemia, and…”
BackgroundResultInfluentialCardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitus
Noh, R. M., Venkatasubramanian, S., Daga, S., Langrish, J. P., Mills, N. L., Lang, N. N., Hoffmann, E. C., Waterhouse, B. R., Newby, D. E., & Frier, B. M. (2017) · Open Heart · doi:10.1136/openhrt-2017-000647 · Cited by 37
“This may be responsible for the modest rise in non-esterified fatty acids seen after SRT2104 administration that could contribute to the change in glycaemic control, leading to insulin resistance via intracellular competition with glucose metabolism.(30) People with T2DM have complex changes to other important glucore…”
Gonna, H., & Ray, K. K. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13691 · Cited by 33
“Insulin mediated suppression of lipolysis of dietary TGs in chylomicrons is impaired in states of insulin resistance.(44) It is likely that hyperinsulinaemia (via PI3-kinase and SREBP1c), rather than insulin resistance per se, contributes to hepatic steatosis and increased VLDL and TGs levels.”
BackgroundReduced miR-181d level in obesity and its role in lipid metabolism via regulation of ANGPTL3
Abu‐Farha, M., Cherian, P., Al‐Khairi, I., Nizam, R., Alkandari, A., Arefanian, H., Tuomilehto, J., Al‐Mulla, F., & Abubaker, J. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-48371-2 · Cited by 31
Davis, D. W., Tallent, R., Navalta, J. W., Salazar, A., Lyons, T. J., & Basu, A. (2020) · Nutrients · doi:10.3390/nu12071902 · Cited by 35
“Further, in apparently healthy young adults, high postprandial NEFA levels increase arterial stiffness and the expression of adhesion molecules [38].”
BackgroundEffects of Dietary Tannic Acid on Obesity and Gut Microbiota in C57BL/6J Mice Fed with High-Fat Diet
Fang, J., Zeng, L., He, Y., Liu, X., Zhang, T., & Wang, Q. (2022) · Foods · doi:10.3390/foods11213325 · Cited by 37
“Obesity has become a pressing public health problem which can increase the risk of many chronic diseases, such as type 2 diabetes and fatty liver and cardiovascular diseases [1,2].”
BackgroundRussell-Jones, D. L., Danne, T., Hermansen, K., Niswender, K. D., Robertson, K. J., Thalange, N. K. S., Vasselli, J. R., Yıldız, B. O., & Häring, H. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12493 · Cited by 31
“Studies have shown that insulin-mediated cerebrocortical activity is reduced in the presence of elevated NEFA, and monounsaturated fatty acids promote insulin-mediated cortical activity [52,53].”
BackgroundInfluentialJi, B., Middleton, J. L., Ernest, B., Saxton, A. M., Lamont, S. J., Campagna, S. R., & Voy, B. H. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00163.2013 · Cited by 37
Cardiorespiratory Fitness, Physical Activity, and Insulin Resistance in Children
Haapala, E. A., Wiklund, P., Lintu, N., Tompuri, T., Väistö, J., Finni, T. J., Tarkka, I. M., KEMPPAINEN, T., BARKER, A. R., Ekelund, U., et al. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002216 · Cited by 32
The Lipidome Fingerprint of Longevity
Jové, M., Mota‐Martorell, N., Pradas, I., Galo‐Licona, J. D., Martin‐Garí, M., Òbis, È., Sol, J., & Pamplona, R. (2020) · Molecules · doi:10.3390/molecules25184343 · Cited by 32
“Additionally, LC-FFAs are also essential by covering mammalian energy needs [158].”
BackgroundChronic Inflammation in Obesity and Cancer Cachexia
Divella, R., Gadaleta‐Caldarola, G., & Mazzocca, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082191 · Cited by 36
Tagliaferri, C., Salles, J., Landrier, J., Giraudet, C., Patrac, V., Lebecque, P., Davicco, M.-J., Chanet, A., Pouyet, C., Dhaussy, A., et al. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0790-0 · Cited by 32
Döşeyici, S., Mehmetoğlu, İ., Toker, A., Yerlikaya, F., & Erbay, E. (2014) · Biotechnic & Histochemistry · doi:10.3109/10520295.2014.883463 · Cited by 29
Sipe, L. M., Yang, C., Ephrem, J., Garren, E. J., Hirsh, J., & Deppmann, C. D. (2017) · Nutrition and Diabetes · doi:10.1038/nutd.2017.13 · Cited by 30
Fappi, A., & Mittendorfer, B. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665119001022 · Cited by 29
Lipid Storage, Lipolysis, and Lipotoxicity in Obesity
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_4 · Cited by 32
Acute effects of fatty acids on autophagy in NPY neurones
Reginato, A., Siqueira, B. P., Miyamoto, J. É., Portovedo, M., Costa, S. D. O., de Fante, T., Rodrigues, H. G., Ignácio-Souza, L. M., Torsoni, M. A., Torsoni, A. S., et al. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12900 · Cited by 30
Sadeer, N. B., Sinan, K. I., Cziáky, Z., Jekő, J., Zengin, G., Jeewon, R., Abdallah, H. H., Al-Dhaheri, Y., Eid, A. H., & Mahomoodally, M. F. (2022) · Molecules · doi:10.3390/molecules27062000 · Cited by 31
“For instance, individuals whose body fat is distributed peripherally have better insulin sensitivity in contrast to individuals with centred body fat distribution [49,50].”
BackgroundTricò, D., Mengozzi, A., Baldi, S., Bizzotto, R., Olaniru, O. E., Toczyska, K., Huang, G. C., Seghieri, M., Frascerra, S., Amiel, S. A., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155247 · Cited by 30
for the GDS group, Apostolopoulou, M., Straßburger, K., Herder, C., Knebel, B., Kotzka, J., Szendroedi, J., & Roden, M. (2016) · Diabetologia · doi:10.1007/s00125-016-4038-9 · Cited by 29
“However, NEFA concentrations vary substantially in obese and T2D patients and may be higher during short-term fasting even in insulin-sensitive humans [7].”
BackgroundZidani, S., Benakmoum, A., Ammouche, A., Benali, Y., Bouhadef, A., & Abbeddou, S. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.11.001 · Cited by 29
Marco‐Ramell, A., Tulipani, S., Palau‐Rodriguez, M., González‐Domínguez, R., Miñarro, A., Jáuregui, O., Sánchez‐Pla, Á., Macías‐González, M., Cardona, F., Tinahones, F. J., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00855 · Cited by 30
Lipid Oxidation Assessed by Indirect Calorimetry Predicts Metabolic Syndrome and Type 2 Diabetes
Pujia, A., Mazza, E., Ferro, Y., Gazzaruso, C., Coppola, A., Doldo, P., Grembiale, R. D., Pujia, R., Romeo, S., & Montalcini, T. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00806 · Cited by 30
The power of three: Retatrutide’s role in modern obesity and diabetes therapy
Abdul-Rahman, T., Roy, P., Ahmed, F. K., Mueller-Gomez, J. L., Sarkar, S., Garg, N., Femi-Lawal, V. O., Wireko, A. A., Thaalibi, H. I., Hashmi, M. U., et al. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177095 · Cited by 27
The RNA binding protein HuR influences skeletal muscle metabolic flexibility in rodents and humans
Mynatt, R. L., Noland, R. C., Elks, C. M., Vandanmagsar, B., Bayless, D. S., Stone, A. C., Ghosh, S., Ravussin, É., & Warfel, J. D. (2019) · Metabolism · doi:10.1016/j.metabol.2019.05.010 · Cited by 30
Barbouche, R., Gaigé, S., Airault, C., Poirot, K., Dallaporta, M., Troadec, J., & Abysique, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-68712-w · Cited by 28
Sex-Specific Effect of High-Fat Diet on Glycerol Metabolism in Murine Adipose Tissue and Liver
Iena, F. M., Jul, J. B., Vegger, J. B., Lodberg, A., Thomsen, J. S., Brüel, A., & Lebeck, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.577650 · Cited by 31
Wagle, S. R., Kovačević, B., Ionescu, C. M., Walker, D., Jones, M., Carey, L., Takechi, R., Mikov, M., Mooranian, A., & Al‐Salami, H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081223 · Cited by 27
“Pancreatic β-cell inflammation has also been connected to prediabetes and diabetes development directly; particularly as healthy β-cells have no natural antioxidant and anti-inflammatory defence capacity [11].”
BackgroundCao, C., Koh, H. E., van Vliet, S., Patterson, B. W., Reeds, D. N., Laforest, R. A., Gropler, R. J., & Mittendorfer, B. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155216 · Cited by 28
Razliqi, R. N., Ahangarpour, A., Mard, S. A., & Khorsandi, L. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121770 · Cited by 30
Altered subcutaneous abdominal adipose tissue lipid synthesis in obese, insulin-resistant humans
Tuvdendorj, D., Chandalia, M., Tumurbaatar, B., Saraf, M. K., Beysen, C., Murphy, E. J., & Abate, N. I. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00194.2013 · Cited by 30
“These findings of altered TG turnover in obese subjects with reduced systemic insulinmediated glucose disposal are consistent with the view of decreased subcutaneous abdominal adipocyte capacity to store FA in patients with insulin resistance (13, 18).”
Chen, K., Wu, Q., Hu, K.-W., Yang, C., Wu, X., Cheung, P., & Williams, K. J. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310358 · Cited by 27
Oxidative Stress and Endothelial Dysfunction: The Pathogenesis of Pediatric Hypertension
Backston, K., Morgan, J., Patel, S., Koka, R., Hu, J., & Raina, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115355 · Cited by 31
“The mitochondrial oxidation of non-esterified fatty acids (NEFAs) generates reducing equivalents for ATP production and is associated with H 2 O 2 accumulation [71–73].”
Sepsis Induces Adipose Tissue Browning in Nonobese Mice But Not in Obese Mice
Ayalon, I., Shen, H., Williamson, L., Stringer, K. F., Zingarelli, B., & Kaplan, J. M. (2017) · Shock · doi:10.1097/shk.0000000000001076 · Cited by 28
“Human data demonstrate that people with obesity have evidence of impaired catecholamine-induced lipolysis (25), but other studies show that there is no relationship between obesity status and fasting fatty acid levels (26).”
Bae, C., Hino, J., Hosoda, H., Miyazato, M., & Kangawa, K. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.08.031 · Cited by 29
Rosiglitazone ameliorates palmitic acid-induced cytotoxicity in TM4 Sertoli cells
Ge, X., Pan, P., Jing, J., Hu, X., Chen, L., Qiu, X., Ma, R., Jueraitetibaike, K., Huang, X., & Yao, B. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0416-0 · Cited by 31
Role of Arginase 2 in Murine Retinopathy Associated with Western Diet-Induced Obesity
Atawia, R. T., Bunch, K. L., Fouda, A. Y., Lemtalsi, T., Eldahshan, W., Xu, Z., SAUL, A. B., Elmasry, K., Al‐Shabrawey, M., Caldwell, R. B., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020317 · Cited by 26
Rivera‐Gonzalez, O., Wilson, N. A., Coats, L. E., Taylor, E. B., & Speed, J. S. (2021) · Clinical Science · doi:10.1042/cs20210549 · Cited by 29
Zhao, M., Zheng, Z., Yin, Z., Zhang, J., Qin, J., Wan, J., & Wang, M. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106832 · Cited by 27
Yu, S.-H., Chen, S.-Y. T., Li, W.-S., Dubey, N. K., Chen, W.-H., Chuu, J., Leu, S., & Deng, W. (2015) · Journal of Diabetes Research · doi:10.1155/2015/723190 · Cited by 30
“This metabolic disorder follows a decreased glucose uptake in muscle tissue and increased lipolysis resulting in fatty acid accumulation [52], which is coherent with the condition of DM.”
One-Year High Fat Diet Affects Muscle-But Not Brain Mitochondria
Jørgensen, T., Grunnet, N., & Quistorff, B. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.27 · Cited by 26
Henson, J. J., Edwardson, C. L., Bodicoat, D. H., Bakrania, K., Davies, M. J., Khunti, K., Talbot, D. C. S., & Yates, T. E. (2017) · Journal of Sports Sciences · doi:10.1080/02640414.2017.1405709 · Cited by 26
Human Adipose Tissue Metabolism in Obesity
Lin, S., & Jensen, M. D. (2025) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes25025 · Cited by 26
“In a detailed review by Karpe et al. 31 published in 2011, the authors found no association between body mass index and fasting plasma FFA levels in combined data from two large-scale population studies.”
He, Y., Tao, Y., Qiu, L., Xu, W., Huang, X., Hua, W., & Tao, X. (2022) · Nutrients · doi:10.3390/nu14204348 · Cited by 25
“As is well-known, obesity causes adipocyte proliferation, and hypertrophy, as well as an increase in the metabolism of adipocytes, thereby reducing the insulin sensitivity of skeletal muscle and producing insulin resistance, and thus, inducing type two diabetes [51].”
BackgroundJohansen, M. Ø., Afzal, S., Vedel‐Krogh, S., Nielsen, S. F., Smith, G. D., & Nordestgaard, B. G. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad330 · Cited by 26
John, A., Vetrivel, U., Krishnakumar, S., & Deepa, P. R. (2015) · Genomics & Informatics · doi:10.5808/gi.2015.13.1.15 · Cited by 27
“This enzyme is a potential target to control bacterial infections by using agents, such as cerulenin and triclosan [10], and an anti-tumor target against different cancers [11] and is also targeted for the treatment of obesity [12, 13] and diabetes [14, 15].”
BackgroundGlaysher, M. A., Ruban, A., Prechtl, C. G., Goldstone, A. P., Miras, A. D., Lord, J., Chhina, N., Falaschetti, E., Johnson, N. A., Al‐Najim, W., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018598 · Cited by 32
Masuku, S., Tsoka-Gwegweni, J. M., & Sartorius, B. (2019) · Journal of Diabetology · doi:10.4103/jod.jod_21_18 · Cited by 30
Panchal, S. K., Poudyal, H., Ward, L. C., Waanders, J., & Brown, L. (2015) · Food & Function · doi:10.1039/c5fo00480b · Cited by 29
Petridi, F., Geurts, J. M. W., Nyakayiru, J., Schaafsma, A., Schaafsma, D., Meex, R. C. R., & Singh‐Povel, C. M. (2024) · Nutrients · doi:10.3390/nu16111721 · Cited by 26
“Furthermore, in addition to studies in the assumed healthy population, future RCTs focusing on the effects of TRF in specific populations (e.g., overweight/obese individuals or T2D patients) should be considered.”
BackgroundManagement of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes
Matikainen, N., & Taskinen, M. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0309-3 · Cited by 27
Matsumoto, K., Yasuyoshi, E., Nishi, K., Honda, Y., Nakaya, M., & Kitamura, S. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.01.046 · Cited by 25
Arabi, Y. M., Tamimi, W., Jones, G., Jawdat, D., Tamim, H., Al-Dorzi, H. M., Sadat, M., Afesh, L., Sakhija, M., & Al-Dawood, A. (2019) · Nutrients · doi:10.3390/nu11020384 · Cited by 24
“FFAs level goes down postprandially due to the anti-lipolytic effect of insulin that is released after carbohydrate intake [13].”
Development of Obesity: The Driver and the Passenger
Kopp, W. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s280146 · Cited by 27
Pati, P., Valcin, J. A., Zhang, D., Neder, T. H., Millender-Swain, T., Allan, J. M., Sedaka, R. S., Jin, C., Becker, B., Pollock, D. M., et al. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00128.2020 · Cited by 25
Lee, Y., Park, E., Park, G.-S., Ko, S., Park, J., Lee, Y.-K., Kim, J., Lee, D., Kang, J., & Lee, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312665 · Cited by 27
“Fatty acids that secrete adipose tissue in the obese state enter the liver, which may cause fatty liver and dyslipidemia in the blood [24].”
BackgroundWang, C., Li, X., Mu, K., Li, L., Wang, S., Zhu, Y., Zhang, M., Ryu, J., Xie, Z., Shi, D., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2971-4 · Cited by 27
“Pancreatic beta cell failure to compensate peripheral insulin needs is a hallmark of type 2 diabetes [1], and obesityinduced insulin resistance is one of the key factors attributed to the increase in peripheral insulin requests [2].”
BackgroundThe role of psychobiological and neuroendocrine mechanisms in appetite regulation and obesity
Paspala, I., Katsiki, N., Kapoukranidou, D., Mikhailidis, D. P., & Tsiligiroglou-Fachantidou, A. (2012) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401206010147 · Cited by 18
Jocken, J. W. E., Goossens, G. H., Popeijus, H. E., Essers, Y. P. G., Hoebers, N., & Blaak, E. E. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.211 · Cited by 26
Agaba, D. C., Migisha, R., Namayanja, R., Katamba, G., Lugobe, H. M., Aheisibwe, H., Twesigomwe, G., & Ashaba, S. (2019) · BioMed Research International · doi:10.1155/2019/1096201 · Cited by 26
“Obesity leads to insulin resistance and then diabetes mellitus [36, 37], and the two conditions predispose to atherosclerosis and then HTN which are all components of MetS.”
BackgroundMarjot, T., Smith, K., Westcott, F., White, S., Johnson, E. M., Srnic, N., Barrett, A., Hall, E., Gralton, K., Dennis, K. M. J. H., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2025.12.004 · Cited by 30
Self-citationFugmann, M., Uhl, O., Hellmuth, C., Hetterich, H., Kammer, N. N., Ferrari, U., Parhofer, K. G., Koletzko, B. V., Seißler, J., & Lechner, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128001 · Cited by 26
“Fasting serum NEFA are not directly derived from nutritional intake but primarily originate from adipose tissue storages [26, 27].”
BackgroundReactive Oxygen Species and Oxidative Stress in Obesity
Büyükuslu, N., & Yiğitbaşı, T. (2015) · Clinical and Experimental Health Sciences · doi:10.5455/musbed.20150604061607 · Cited by 20
Nifuroxazide ameliorates lipid and glucose metabolism in palmitate-induced HepG2 cells
Liu, J.-Y., Zhang, Y., Song, L., Zhang, L., Yang, F., Zhu, X.-R., Cheng, Z., Cao, X., & Yang, J.-K. (2019) · RSC Advances · doi:10.1039/c9ra06527j · Cited by 25
Insulin Action, Glucose Homeostasis and Free Fatty Acid Metabolism: Insights From a Novel Model
Stefanovski, D., Punjabi, N. M., Boston, R. C., & Watanabe, R. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.625701 · Cited by 28
NGBR Is Required to Ameliorate Type 2 Diabetes in Mice by Enhancing Insulin Sensitivity
Chen, Y., Hu, W., Li, Q., Zhao, S., Zhao, D., Zhang, S., Wei, Z., Yang, X., Chen, Y., Li, X., et al. (2020) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100624 · Cited by 25
Yan, W. S., Bai, R., Zheng, Q., Yang, X., Shi, Y., Yang, R., Jiang, C., Wang, X., & Li, X. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2227844 · Cited by 23
“the oxidative stress response and thus exacerbate insulin resistance [38], which may be due to the structural homology between PFass and some fatty acids in the human body, increasing the expression of genes related to fatty acid oxidation [39,40].”
BackgroundMarrow Adipose Tissue Expansion Coincides with Insulin Resistance in MAGP1-Deficient Mice
Walji, T. A., Turecamo, S. E., Sanchez, A. C., Anthony, B. A., Abou‐Ezzi, G., Scheller, E. L., Link, D. C., Mecham, R. P., & Craft, C. S. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00087 · Cited by 25
Panda, V., Kinjal, M., Sudhamani, S., Nandave, M., & Ojha, S. K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2359389 · Cited by 23
“A major contributor to the development of insulin resistance is an overabundance of circulating FFA released from an expanded adipose tissue mass [27].”
BackgroundNo Influence of Overweight/Obesity on Exercise Lipid Oxidation: A Systematic Review
Arad, A. D., Basile, A. J., Albu, J., & DiMenna, F. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051614 · Cited by 25
“However, a review of literature suggests an obesity-related downregulation of lipolysis per quantity of fat mass [65] and reduced lipolytic response to exercise for overweight/obese individuals [53] that offsets the advantage.”
BackgroundKhatun, M. A., Sato, S., & Konishi, T. (2020) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2020.03.004 · Cited by 24
Fetuin‐A excess expression amplifies lipid induced apoptosis and β‐cell damage
Mukhuty, A., Fouzder, C., & Kundu, R. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30499 · Cited by 23
“Excess supply of circulating FFAs also results in insulin re- sistance, a common defect in metabolic functions (Kahn & Flier, 2000; Karpe et al., 2011).”
BackgroundSubcutaneous Adipose Tissue Metabolic Function and Insulin Sensitivity in People With Obesity
Koh, H. E., van Vliet, S., Pietka, T., Meyer, G. A., Razani, B., Laforest, R. A., Gropler, R. J., & Mittendorfer, B. (2021) · Diabetes · doi:10.2337/db21-0160 · Cited by 25
Anholm, C., Kumarathurai, P., Samkani, A., Pedersen, L. R., Boston, R. C., Nielsen, O. W., Kristiansen, O. P., Fenger, M., Madsbad, S., Sajadieh, A., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13761 · Cited by 22
“Nonesterified fatty acids (NEFA) are important oxidative fuels, but elevated levels (lipotoxicity) play a role in the development of IR in individuals with obesity and T2DM; however, it is suggested that other pathophysiologic pathways may explain the relationship between NEFA and IR in obesity.(1) An elevated plasma…”
BackgroundYousif, M. D., Calder, M. D., Du, J. T., Ruetz, K. N., Crocker, K., Urquhart, B. L., Betts, D. H., Rafea, B. A., & Watson, A. J. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00223-5 · Cited by 24
“High BMI is associated with elevated NEFA levels in vivo [13].”
BackgroundExploring the Genetic Conception of Obesity via the Dual Role of FoxO
Behl, T., Kaur, I., Sehgal, A., Singh, S., Zengin, G., Negruţ, N., Nistor-Cseppento, C. D., Pavel, F. M., Aron, R. A. C., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063179 · Cited by 22
“In patients with obesity, there are increased fatty acid concentrations [66] and cholesterol levels, thus exhibiting greater fatty cell mass.”
BackgroundSerum concentration of fatty acids in children with obesity and nonalcoholic fatty liver disease
Kopiczko, N., Bobrus‐Chociej, A., Harasim‐Symbor, E., Tarasów, E., Wojtkowska, M., Chabowski, A., & Lebensztejn, D. M. (2021) · Nutrition · doi:10.1016/j.nut.2021.111541 · Cited by 23
A network analysis of depressive symptoms and metabolomics
Rydin, A. O., Milaneschi, Y., Quax, R., Li, J., Bosch, J. A., Schoevers, R. A., Giltay, E. J., Penninx, B. W. J. H., & Lamers, F. (2023) · Psychological Medicine · doi:10.1017/s0033291723001009 · Cited by 23
“Both VLDL and fatty acids share associations with BMI (Arner & Rydén, 2015; Björnson, Adiels, Taskinen, & Borén, 2017; Boden, 2008; Karpe, Dickmann, & Frayn, 2011; Lewis, Uffelman, Szeto, & Steiner, 1993; Mittendorfer, Patterson, & Klein, 2003; Figure 3.”
Exploring the Interplay between Fatty Acids, Inflammation, and Type 2 Diabetes
Nicholas, D., Mbongue, J. C., Garcia-Pérez, D., Sorensen, D. W., Bennit, H. R. F., León, M. A. D., & Langridge, W. H. R. (2024) · Immuno · doi:10.3390/immuno4010006 · Cited by 26
“In individuals with obesity, there is a significant rise in the release of pro-inflammatory substances, including non-esterified fatty acids (FAs) and cytokines [13].”
Adipocyte miR-200b/a/429 ablation in mice leads to high-fat-diet-induced obesity
Tao, C., Ren, H., Xu, P., Cheng, J. R., Huang, S., Zhou, R., Mu, Y., Yang, S., Qi, D., Wang, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12080 · Cited by 24
“This finding is in agreement with previous observations in many obese individuals [23] and HSL haploinsufficient mice [24].”
ResultHigh-fat diet effects on metabolic responses to chronic stress
Nemati, M., Zardooz, H., Rostamkhani, F., Abadi, A., & Foroughi, F. (2017) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1295083 · Cited by 23
“It has been shown that high-fat diet causes these alterations by increasing fat deposits, especially intra-abdominal fat (Costa et al., 2011a, 2011b; Gower & Goss, 2015), and also by increasing the plasma levels of free fatty acids (Karpe et al., 2011; Ragheb & Medhat, 2011; Sears & Perry, 2015).”
BackgroundInfluentialGonzalez, J. T., Richardson, J. D., Chowdhury, E. A., Koumanov, F., Holman, G. D., Cooper, S., Thompson, D., Tsintzas, K., & Betts, J. A. (2017) · The Journal of Physiology · doi:10.1113/jp275113 · Cited by 26
“A physiological down-regulation of adipose tissue non-esterified fatty acid (NEFA) release in obesity has previously been suggested whereby, with increasing adiposity, the down-regulation of NEFA release per kilogram of adipose tissue preserves circulating NEFA homeostasis (Karpe et al. 2011).”
BackgroundPetrák, O., Klímová, J., Mráz, M., Haluzíková, D., Doležalová, R., Kratochvílová, H., Lacinová, Z., Novák, K., Michalský, D., Waldauf, P., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa154 · Cited by 24
Hong, J.-Y., Park, K., Kim, J.-D., Hwang, W.-M., & Lim, D.-M. (2020) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes20040 · Cited by 23
Huang, N. K., Bůžková, P., Matthan, N. R., Djoussé, L., Hirsch, C. H., Kizer, J. R., Longstreth, W. T., Mukamal, K. J., & Lichtenstein, A. H. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019135 · Cited by 23
Metadata
- Authors
- Karpe, F., Dickmann, J. R., & Frayn, K. N.
- Affiliations
- John Radcliffe Hospital (GB)
- University of Oxford (GB)
- Corresponding author
- Karpe, Fredrik
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-09-16
- Volume
- 60
- Issue
- 10
- Pages
- 2441-2449
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3178283
- OpenAlex
- W2152688545
- Cited by
- 896
- References
- 91
- Citations by year
- 2026: 29 · 2025: 33 · 2024: 41 · 2023: 45 · 2022: 73 · 2021: 72 · 2020: 76 · 2019: 74 · 2018: 68 · 2017: 85 · 2016: 76 · 2015: 78 · 2014: 57 · 2013: 53 · 2012: 31
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- University of Oxford
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- free fatty acids, obesity, insulin resistance, adipose tissue lipolysis, fatty acid mobilization, plasma albumin binding, triacylglycerol mobilization, insulin signaling
- MeSH terms
- Adipose Tissue, Diabetes Mellitus, Fatty Acids, Nonesterified, Humans, Insulin Resistance, Obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.